Analyst Reco. Accolade, Inc.

Equities

ACCD

US00437E1029

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-30 EDT			5-day change	1st Jan Change
7.63 ^USD	-6.84%		-18.40%	-36.47%

04-30	Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating	MT
04-26	Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating	04-30	MT
Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating	04-26	MT
Stifel Adjusts Accolade's Price Target to $13 From $15, Keeps Buy Rating	04-22	MT
Leerink Partners Initiates Accolade at Outperform Rating With $16 Price Target	02-26	MT
Raymond James Adjusts Accolade's Price Target to $16 From $12, Keeps Outperform Rating	01-09	MT
Stifel Cuts Accolade's Price Target to $15 From $17, Keeps Buy Rating	01-04	MT
Piper Sandler Adjusts Accolade's Price Target to $12 From $15, Maintains Overweight Rating	11-22	MT
Canaccord Genuity Adjusts Accolade Price Target to $17 From $18, Maintains Buy Rating	23-10-05	MT
Truist Securities Adjusts Price Target on Accolade to $15 From $17, Keeps Buy Rating	23-10-05	MT
Raymond James Adjusts Price Target on Accolade to $12 From $15, Keeps Outperform Rating	23-10-05	MT
Stifel Adjusts Price Target on Accolade to $17 From $15, Maintains Buy Rating	23-06-30	MT
Wells Fargo Adjusts Price Target on Accolade to $14 From $13, Maintains Equalweight Rating	23-06-30	MT
Credit Suisse Adjusts Accolade's Price Target to $15 From $13, Keeps Neutral Rating	23-06-30	MT
Needham Raises Price Target on Accolade to $17 From $15, Maintains Buy Rating	23-06-30	MT
BofA Upgrades Accolade to Buy From Neutral, Price Target is $16.50	23-05-24	MT
DA Davidson Raises Accolade's Price Target to $16 From $14, Keeps Buy Rating	23-05-01	MT
Guggenheim Adjusts Accolade's Price Target to $18 From $16, Keeps Buy Rating	23-04-28	MT
Canaccord Genuity Adjusts Price Target on Accolade to $18 From $14, Maintains Buy Rating	23-04-28	MT
Morgan Stanley Adjusts Accolade's Price Target to $14 From $11, Keeps Equalweight Rating	23-04-28	MT
Credit Suisse Raises Accolade's Price Target to $13 From $11, Notes Elevated Expectations into Fiscal Q4 Keeps Neutral Rating	23-04-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Accolade, Inc.

Equities

ACCD

US00437E1029

Analyst Reco.

Filters